Загрузка...
A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations
The use of drug combinations in clinical trials is increasingly common during the last years since a more favorable therapeutic response may be obtained by combining drugs. In phase I clinical trials, most of the existing methodology recommends a one unique dose combination as “optimal,” which may r...
Сохранить в:
| Опубликовано в: : | Biom J |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7483235/ https://ncbi.nlm.nih.gov/pubmed/32150296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bimj.201900095 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|